Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2617649rdf:typepubmed:Citationlld:pubmed
pubmed-article:2617649lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:2617649lifeskim:mentionsumls-concept:C0237401lld:lifeskim
pubmed-article:2617649lifeskim:mentionsumls-concept:C0003320lld:lifeskim
pubmed-article:2617649lifeskim:mentionsumls-concept:C0003241lld:lifeskim
pubmed-article:2617649lifeskim:mentionsumls-concept:C0006137lld:lifeskim
pubmed-article:2617649lifeskim:mentionsumls-concept:C0441889lld:lifeskim
pubmed-article:2617649lifeskim:mentionsumls-concept:C0301872lld:lifeskim
pubmed-article:2617649lifeskim:mentionsumls-concept:C0036319lld:lifeskim
pubmed-article:2617649lifeskim:mentionsumls-concept:C0205146lld:lifeskim
pubmed-article:2617649lifeskim:mentionsumls-concept:C0205250lld:lifeskim
pubmed-article:2617649lifeskim:mentionsumls-concept:C0243130lld:lifeskim
pubmed-article:2617649lifeskim:mentionsumls-concept:C1704788lld:lifeskim
pubmed-article:2617649lifeskim:mentionsumls-concept:C0030523lld:lifeskim
pubmed-article:2617649pubmed:issue6lld:pubmed
pubmed-article:2617649pubmed:dateCreated1990-3-1lld:pubmed
pubmed-article:2617649pubmed:abstractTextSera from individuals living in 2 areas endemic for Schistosoma mansoni in Minas Gerais, Brazil were assayed for the presence of antibodies against paramyosin and glutathione-S-transferase (GST), molecules previously implicated as vaccine immunogens from studies in laboratory hosts. A group was identified consisting of subjects who were stool-negative and had no record of previous infection but who were seropositive by enzyme-linked immunosorbent assay against crude adult worm antigen (SWAP). These individuals had anti-paramyosin antibody levels which were dramatically elevated with respect to those measured in infected (stool-positive) individuals living in the same endemic area. In contrast, the same 2 groups of stool-positive and stool-negative subjects could not be distinguished on the basis of their seroreactivity to either GST or SWAP. After chemotherapy, anti-paramyosin antibodies rose above pre-treatment levels and remained elevated in those individuals who became stool-negative. In contrast, anti-paramyosin antibodies decreased to pretreatment values in drug-treated individuals who failed to show complete parasitological cure. These results suggest that the immune response of humans to paramyosin may play a role in natural resistance to schistosome infection, and that an elevated antibody level against this antigen may be a useful correlate of drug-induced cure.lld:pubmed
pubmed-article:2617649pubmed:languageenglld:pubmed
pubmed-article:2617649pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2617649pubmed:citationSubsetIMlld:pubmed
pubmed-article:2617649pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2617649pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2617649pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2617649pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2617649pubmed:statusMEDLINElld:pubmed
pubmed-article:2617649pubmed:issn0035-9203lld:pubmed
pubmed-article:2617649pubmed:authorpubmed-author:KatzNNlld:pubmed
pubmed-article:2617649pubmed:authorpubmed-author:SherAAlld:pubmed
pubmed-article:2617649pubmed:authorpubmed-author:GazzinelliGGlld:pubmed
pubmed-article:2617649pubmed:authorpubmed-author:CarvalhoO SOSlld:pubmed
pubmed-article:2617649pubmed:authorpubmed-author:Correa-Olivei...lld:pubmed
pubmed-article:2617649pubmed:authorpubmed-author:PearceE JEJlld:pubmed
pubmed-article:2617649pubmed:authorpubmed-author:OliveiraG CGClld:pubmed
pubmed-article:2617649pubmed:authorpubmed-author:GolgherD BDBlld:pubmed
pubmed-article:2617649pubmed:authorpubmed-author:BahiaL GLGlld:pubmed
pubmed-article:2617649pubmed:issnTypePrintlld:pubmed
pubmed-article:2617649pubmed:volume83lld:pubmed
pubmed-article:2617649pubmed:ownerNLMlld:pubmed
pubmed-article:2617649pubmed:authorsCompleteYlld:pubmed
pubmed-article:2617649pubmed:pagination798-804lld:pubmed
pubmed-article:2617649pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2617649pubmed:meshHeadingpubmed-meshheading:2617649-...lld:pubmed
pubmed-article:2617649pubmed:meshHeadingpubmed-meshheading:2617649-...lld:pubmed
pubmed-article:2617649pubmed:meshHeadingpubmed-meshheading:2617649-...lld:pubmed
pubmed-article:2617649pubmed:meshHeadingpubmed-meshheading:2617649-...lld:pubmed
pubmed-article:2617649pubmed:meshHeadingpubmed-meshheading:2617649-...lld:pubmed
pubmed-article:2617649pubmed:meshHeadingpubmed-meshheading:2617649-...lld:pubmed
pubmed-article:2617649pubmed:meshHeadingpubmed-meshheading:2617649-...lld:pubmed
pubmed-article:2617649pubmed:meshHeadingpubmed-meshheading:2617649-...lld:pubmed
pubmed-article:2617649pubmed:meshHeadingpubmed-meshheading:2617649-...lld:pubmed
pubmed-article:2617649pubmed:meshHeadingpubmed-meshheading:2617649-...lld:pubmed
pubmed-article:2617649pubmed:meshHeadingpubmed-meshheading:2617649-...lld:pubmed
pubmed-article:2617649pubmed:meshHeadingpubmed-meshheading:2617649-...lld:pubmed
pubmed-article:2617649pubmed:meshHeadingpubmed-meshheading:2617649-...lld:pubmed
pubmed-article:2617649pubmed:meshHeadingpubmed-meshheading:2617649-...lld:pubmed
pubmed-article:2617649pubmed:meshHeadingpubmed-meshheading:2617649-...lld:pubmed
pubmed-article:2617649pubmed:meshHeadingpubmed-meshheading:2617649-...lld:pubmed
pubmed-article:2617649pubmed:meshHeadingpubmed-meshheading:2617649-...lld:pubmed
pubmed-article:2617649pubmed:meshHeadingpubmed-meshheading:2617649-...lld:pubmed
pubmed-article:2617649pubmed:meshHeadingpubmed-meshheading:2617649-...lld:pubmed
pubmed-article:2617649pubmed:articleTitleThe human immune response to defined immunogens of Schistosoma mansoni: elevated antibody levels to paramyosin in stool-negative individuals from two endemic areas in Brazil.lld:pubmed
pubmed-article:2617649pubmed:affiliationCentro de Pesquisas Rene Rachou, Fundaçao Oswaldo Cruz, Minas Gerais, Brazil.lld:pubmed
pubmed-article:2617649pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2617649pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
pubmed-article:2617649pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2617649lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2617649lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2617649lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2617649lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2617649lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2617649lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2617649lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2617649lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2617649lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2617649lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2617649lld:pubmed